Skip to content
The Policy VaultThe Policy Vault

Viekira PakMedica

Chronic Hepatitis C Virus (HCV), Genotype 1a

Initial criteria

  • age ≥ 18 years
  • Patient does not have cirrhosis OR patient has cirrhosis
  • The medication is prescribed in combination with ribavirin
  • The medication is prescribed by or in consultation with a gastroenterologist, hepatologist, infectious diseases physician, or a liver transplant physician

Reauthorization criteria

  • Patient has been started on Viekira Pak and needs remaining duration to complete course of therapy

Approval duration

12 weeks without cirrhosis OR 24 weeks with cirrhosis